Compare Essex Property Trust, Inc. (ESS) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs IDEXX Laboratories, Inc. — how do they compare? Essex Property Trust, Inc. trades at $271.57 (market cap $17.26B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.3× Essex Property Trust, Inc.'s market cap, and Essex Property Trust, Inc. pays a 3.86% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Essex Property Trust, Inc. for 111 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| ESS | IDXX | |
|---|---|---|
Market Cap | $17.26B | $40.43B |
Volume | 454,464 | 692,164 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $766.68 |
52-Week Low | $239.61 | $504.70 |
Typical Hold Time | 111 Days | 46 Days |
Enterprise Value | $23.86B | $41.32B |
Dividend Yield | 3.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESS trades at $271.57, up 1.31% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 results beating FFO guidance and raised full-year outlook, while resolving major litigation. Fundamentals show solid revenue growth to $1.89B in 2025 with 21.48% net margins, though valuation multiples remain elevated with P/E of 41.83.
Outlook remains cautiously optimistic with analyst consensus target of $303.41 offering 12% upside potential. Key opportunities include sustained West Coast multifamily demand and operational efficiency, while risks involve elevated debt levels and potential regional economic headwinds affecting rental markets.
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
